Chemical Name | Vericiguat |
Synonyms | UNII-LV66ADM269;Methyl (4,6-diamino-2-(5-fluoro-1-((2-fluorophenyl)methyl)-1H-pyrazolo(3,4-b)pyridin-3-yl(pyrimidin-5-yl)carbamate;BAY1021189;Methyl (4,6-diamino-2-(5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-5-yl)carbamate;Methyl N-(4,6-diamino-2-(5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo(3,4-b)pyridin-3-yl)pyrimidin-5-yl)carbamate;Expand |
CAS No. | 1350653-20-1 |
Molecular Formula | C19H16F2N8O2 |
Molecular Weight | 426.38000 |
PSA | 151.08000 |
LogP | 3.08240 |
Vericiguat uses
Vericiguat is a novel oral soluble guanylate cyclase (sGC) stimulator that enhances the cyclic guanosine monophosphate (GMP) production pathway, by directly stimulating soluble guanylate cyclase activity, as well as sensitizing soluble guanylate cyclase to endogenous NO. Vericiguat was initially developed for potential to reduce mortality and morbidity associated with chronic heart failure with reduced ejection fraction.
Vericiguat CAS 1350653-20-1 Storage
Vericiguat CAS 1350653-20-1 should be stored in a sealed container in a cool, dry and ventilated place at low temperature.
